Sort
21,453 grants matching “tuberculosis”
Implementation Research for Vulnerable Women in South Africa
$611,493Wendee M Wechsberg · Research Triangle Institute · R01 · FY2015 · AA
Human T cell responses permissive for progression to active TB disease
$611,486Joel D. Ernst · Emory University · U19 · FY2019 · AI
The Role of Inflammation in CNS Mechanisms of Anhedonia and Psychomotor Slowing in Depressed PWH as Determined using a Next Generation TNF Antagonist
$611,429Jennifer C Felger · Emory University · R01 · FY2025 · MH
Rescue of CF phagocyte function with CFTR modulator therapy
$611,287Benjamin T Kopp · Research Inst Nationwide Children'S Hosp · R01 · FY2022 · HL
IL-2/Treg-based immunity to TB and AIDS-related TB
$611,280Zheng W Chen · University Of Illinois At Chicago · R01 · FY2014 · HL
TUBERCULOSIS CONTROL PROGRAM AND AIDS
$611,026Heidi Jenkins · Connecticut State Dept Of Public Health · U52 · FY2008 · PS
TUBERCULOSIS CONTROL PROGRAM AND AIDS
$611,026Heidi Jenkins · Connecticut State Dept Of Public Health · U52 · FY2009 · PS
Human Genetic Dissection of Exit from Latency in Tuberculosis
$610,909Jean-Laurent Casanova · Weill Medical Coll Of Cornell Univ · U19 · FY2020 · AI
Prevent TB: Application of choice architecture to implement TB preventive therapy in South Africa
$610,825Christopher J Hoffmann · Johns Hopkins University · R01 · FY2021 · AI
Immunometabolic regulations of pulmonary TB pathogenesis by adiposetissue
$610,816Jyothi Falguni Nagajyothi · Hackensack University Medical Center · R01 · FY2020 · AI
Immune Determinants of the Course of Mycobacterium tuberculosis infection and Disease
$610,717Padmini Salgame · Rutgers Biomedical And Health Sciences · U19 · FY2025 · AI
A multi-scale model to predict outcomes of immunomodulation and drug therapy duri
$610,696Denise E Kirschner · University Of Michigan At Ann Arbor · R01 · FY2011 · EB
The Role of Inflammation in CNS Mechanisms of Anhedonia and Psychomotor Slowing in Depressed PWH as Determined using a Next Generation TNF Antagonist
$610,645Jennifer C Felger · Emory University · R01 · FY2021 · MH
Host Response to TB and AIDS
$610,625New York University School Of Medicine · R01 · FY2004 · HL
Fox COBRE Phase II Admin Core
$610,481Joseph M Fox · University Of Delaware · P20 · FY2021 · GM
Passive-Active Immunization Strategies Against Pediatric AIDS
$610,378Marta L Marthas · University Of California At Davis · R01 · FY2008 · AI
SAIA-TB: Using the Systems Analysis and Improvement Approach (SAIA) to prevent TB in rural South Africa
$610,352Brittney Jayne Van De Water · Boston College · R01 · FY2024 · NR
DRUG DISCOVERY FOR PERSISTENT TUBERCULOSIS
$610,194Texas Agrilife Research · P01 · FY2002 · AI
Memory, Phenotype, and Function of TB-reactive Human MR1 Restricted T cells
$609,882David M. Lewinsohn · Oregon Health & Science University · R01 · FY2020 · AI
The Role of Inflammation in CNS Mechanisms of Anhedonia and Psychomotor Slowing in Depressed PWH as Determined using a Next Generation TNF Antagonist
$609,667Jennifer C Felger · Emory University · R01 · FY2023 · MH
Clinical Suspicion of TB: A Technology Assessment Tool
$609,640University Of California San Diego · R01 · FY2005 · AI
Transcriptome and proteome remodeling by Mycobacterium tuberculosis MazF toxins
$609,633Nancy Ann Woychik · Rbhs-Robert Wood Johnson Medical School · R01 · FY2022 · AI
Wisconsin Tuberculosis Elimination and Laboratory Cooperative Agreement
$609,391Lorna Will · Wisconsin Department Of Health Services · U52 · FY2015 · PS
Eliciting lung-localized CD4 T cell responses against Mycobacterium tuberculosis in preventive and post-exposure settings
$609,293Kevin B Urdahl · Seattle Biomedical Research Institute · R01 · FY2017 · AI
TB Vaccine Candidates Found in Patients' Bodily Fluids and Murine MHC-1 Molecule
$609,083Antonio Campos-Neto · Ada Forsyth Institute, Inc. · R01 · FY2008 · AI